Balancing efficacy and toxicity of a fibroblast activation protein dependent tetravalent CD40 agonist antibody for cancer therapy

被引：1
|
作者：
Chen, Simeng
Lin, Yuan
Zhou, Xiaoru
Sun, Xing
Yang, Changyong
Liao, Cheng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2366
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2366
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combination CD40 agonist and PD-1 antagonist antibody therapy enhances vaccine induced T cell responses in non-immunogenic cancers
    Ma, Hayley S.
    Torres, Evanthia Roussos
    Poudel, Bibhav
    Robinson, Tara
    Christmas, Brian
    Cruz, Kayla
    Woolman, Skylar
    Rafie, Christine
    Scott, Blake
    Wall, Valerie
    Armstrong, Todd
    Jaffee, Elizabeth
    CANCER RESEARCH, 2018, 78 (13)
  • [42] A novel PD1-CD40 bispecific antibody YH008 induces potent anti-tumor activity in vivo by PD1 dependent activation of CD40 signaling.
    Liu, Baihong
    Hui, Li
    Liu, Chonghui
    Li, Zhihong
    Pan, Fangxia
    Yang, Benny
    Lin, Qingcong
    CANCER RESEARCH, 2021, 81 (13)
  • [43] Early safety and efficacy from a phase I open-label clinical study of LVGN7409 (CD40 agonist antibody) in patients with advanced or metastatic malignancies.
    Fu, Siqing
    Vandross, Andrae Lavon
    Hsu, Yi Hsin
    Shi, Naiyi
    Jiang, Lynn
    Su, Fusheng
    Wang, Jieyi
    Chan, C. Hubert
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Mitazalimab, a potent CD40 agonist in combination with FOLFIRINOX demonstrates changes consistent with increased immune activation in TME and peripheral blood in a preclinical pancreatic cancer tumor model
    Smith, Karin Enell
    Jimenez, David Gomez
    Thagesson, Mia
    Nilsson, Anneli
    de Coana, Yago Pico
    Ambarkhane, Sumeet
    Ellmark, Peter
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Synergistic Effects of CD40 Agonist Antibody and DC-Derived Exosomes Enhance Anti-Tumor Efficacy by Modulating the Tumor Microenvironment and Reducing Metastasis in a Murine Melanoma Model
    Gaur, Vidit
    Bhattacharyya, Jayanta
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [46] The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
    Gladue, Ronald P.
    Paradis, Timothy
    Cole, Susan H.
    Donovan, Carol
    Nelson, Robin
    Alpert, Robbin
    Gardner, Joe
    Natoli, Ed
    Elliott, Eileen
    Shepard, Richard
    Bedian, Vahe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 1009 - 1017
  • [47] The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice
    Ronald P. Gladue
    Timothy Paradis
    Susan H. Cole
    Carol Donovan
    Robin Nelson
    Robbin Alpert
    Joe Gardner
    Ed Natoli
    Eileen Elliott
    Richard Shepard
    Vahe Bedian
    Cancer Immunology, Immunotherapy, 2011, 60 : 1009 - 1017
  • [48] Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the β2 Integrin Mac-1 and Protein Kinase C Zeda (PKCζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst
    Jin, Rong
    Yu, Shiyong
    Song, Zifang
    Zhu, Xiaolei
    Wang, Cuiping
    Yan, Jinchuan
    Wu, Fusheng
    Nanda, Anil
    Granger, D. Neil
    Li, Guohong
    PLOS ONE, 2013, 8 (06):
  • [49] PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer
    Chaib, Mehdi
    Sipe, Laura M. M.
    Yarbro, Johnathan R. R.
    Bohm, Margaret S. S.
    Counts, Brittany R. R.
    Tanveer, Ubaid
    Pingili, Ajeeth K. K.
    Daria, Deidre
    Marion, Tony N. N.
    Carson, James A. A.
    Thomas, Paul G. G.
    Makowski, Liza
    CANCER LETTERS, 2022, 531 : 98 - 108
  • [50] First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer
    Lakhani, Nehal J.
    Stewart, Daphne
    Richardson, Debra L.
    Dockery, Lauren E.
    Van Le, Linda
    Call, Justin
    Rangwala, Fatima
    Wang, Guanfang
    Ma, Bo
    Metenou, Simon
    Huguet, Jade
    Offman, Elliot
    Pandite, Lini
    Hamilton, Erika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
12345